相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Fibrosis-4 index at diagnosis can predict all-cause mortality in patients with rheumatoid arthritis: A retrospective monocentric study
Seung Up Kim et al.
MODERN RHEUMATOLOGY (2020)
Fibrosis-4 index at diagnosis is associated with all-cause mortality in patients with microscopic polyangiitis and granulomatosis with polyangiitis
Hee Jin Park et al.
BMC GASTROENTEROLOGY (2019)
Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity A Scientific Statement From the American Heart Association
Lin Y. Chen et al.
CIRCULATION (2018)
Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants
Daniele Pastori et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Three-Year Clinical Outcomes Associated With Warfarin vs. Direct Oral Anticoagulant Use Among Japanese Patients With Atrial Fibrillation - Findings From the SAKURA AF Registry
Yasuo Okumura et al.
CIRCULATION JOURNAL (2018)
Liver Disease as a Predictor of New-Onset Atrial Fibrillation
William A. Huang et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Atrial fibrillation: Utility of CHADS2 and CHA2DS2-VASc scores as predictors of readmission, mortality and resource utilization
Sopan Lahewala et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Cirrhosis is a risk factor for atrial fibrillation: A nationwide, population-based study
HyunJung Lee et al.
LIVER INTERNATIONAL (2017)
Liver stiffness assessed by Fibrosis-4 index predicts mortality in patients with heart failure
Yu Sato et al.
OPEN HEART (2017)
Current use of direct oral anticoagulants for atrial fibrillation in Japan: Findings from the SAKURA AF Registry
Yasuo Okumura et al.
JOURNAL OF ARRHYTHMIA (2017)
Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study)
Aki J. Karajamaki et al.
PLOS ONE (2015)
Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2013) - Digest Version
Hiroshi Inoue et al.
CIRCULATION JOURNAL (2014)
Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population
Yoshio Sumida et al.
BMC GASTROENTEROLOGY (2012)
Chronic Kidney Disease and CHADS2 Score Independently Predict Cardiovascular Events and Mortality in Patients With Nonvalvular Atrial Fibrillation
Keiko Nakagawa et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)
Thierry Poynard et al.
BMC GASTROENTEROLOGY (2010)
Update on the Association of Inflammation and Atrial Fibrillation
Parag Patel et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2010)
Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
Alan S. Go et al.
CIRCULATION (2009)
Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Amy G. Shah et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Epidemiology of atrial fibrillation
Michael W. Rich
JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY (2009)
FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and FibroTest
Adays Vallet-Pichard et al.
HEPATOLOGY (2007)
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection
Richard K. Sterling et al.
HEPATOLOGY (2006)
Relationships between sinus rhythm, treatment, and survival in the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study
SD Corley et al.
CIRCULATION (2004)
Selecting patients with atrial fibrillation for anticoagulation - Stroke risk stratification in patients taking aspirin
BF Gage et al.
CIRCULATION (2004)
Validation of clinical classification schemes for predicting stroke - Results from the national registry of Atrial Fibrillation
BF Gage et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
分享论文
